Cytokinetics Inc (CYTK) — Capital Reinvestment Ratio
Latest as of December 2020:
0.13x
Cytokinetics Inc (CYTK) has a Capital Reinvestment Ratio of 0.13x as of December 2020, meaning it reinvests 0% of its operating cash flow ($52.15 Million) in capital expenditures ($6.55 Million). See CYTK cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.13x
Capex / Operating Cash Flow
Operating Cash Flow
$52.15 Million
USD
Capital Expenditures
$6.55 Million
USD
Data as of
Dec 2020
Most recent filing
Cytokinetics Inc Capital Reinvestment Ratio (2009–2020)
This chart tracks Cytokinetics Inc's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Cytokinetics Inc (2009–2020)
Year-by-year Capital Reinvestment Ratio for Cytokinetics Inc from 2009 to 2020. For live market cap and broader valuation context, see CYTK market cap.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 1.24x | $8.94 Million | $11.05 Million | ▲ +2763.6% |
| 2016 | 0.04x | $36.98 Million | $1.60 Million | ▼ -62.5% |
| 2015 | 0.12x | $4.88 Million | $562.00K | ▲ +76.1% |
| 2009 | 0.07x | $8.42 Million | $550.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow